Legarda Medical Leave Amid Graft Probe
Analysis based on 8 articles · First reported Aug 24, 2026 · Last updated Sep 21, 2026
The event has limited direct market impact, though the graft probe into P10 billion in alleged ghost solar projects could weigh on sentiment toward Philippine renewable energy firms and raise governance concerns. Prolonged absence of a sitting senator during an impeachment trial adds political uncertainty that may modestly pressure Philippine assets.
Senator Loren Legarda of the Philippines has repeatedly extended her medical leave from the Philippines — Senate of the Philippines, most recently through October 9, 2026, according to Senate Secretary Renato Baja. Legarda first filed medical leave from August 3 to 5, 2026, and has since filed six consecutive extensions, mostly covering Mondays to Wednesdays, the days set for Senate plenary sessions and the impeachment trial of Vice President Sara Duterte. Legarda reportedly left the Philippines for France on August 2, 2026, days after the Office of the Ombudsman announced a preliminary investigation into her and her son, Batangas First District Representative Leandro Leviste, over alleged graft and plunder involving over P10 billion in supposed ghost solar power projects tied to Leviste's renewable energy firm. Legarda has denied the allegations as utterly false and baseless. Colleagues including Senators Juan Miguel Zubiri, Panfilo Lacson, and Senate President Sherwin Gatchalian said Legarda is receiving treatment for a serious lung illness, though she has not publicly disclosed details of her condition. Lacson dismissed reports that Legarda was seeking asylum as fake news. The Philippines — National Bureau of Investigation reported that Legarda left the country on August 2. Her prolonged absence has raised questions about her participation in the Senate impeachment trial and her political future.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard